Sort
50,496 grants matching “lung cancer”
Vaccine and Drug Combination Therapy for Human Cancers
$524,358James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Vaccine and radiation for the therapy of human cancers
$524,358James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
PROMISE Trial: Substudy to Assess for Effective Dose of Radiation
$524,281Andrew Einstein · Columbia University Health Sciences · R01 · FY2015 · HL
Elucidating pro-metastatic collagen modifying activities of lysyl hydroxylase 2
$524,219Jonathan M Kurie · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Reducing cardiac toxicity with deep learning and MRI-guided radiation therapy
$524,106Carri Kaye Glide-Hurst · University Of Wisconsin-Madison · R01 · FY2021 · HL
UCSF Project 1
$524,054Trever G Bivona · University Of California, San Francisco · U54 · FY2021 · CA
Improving Risk Factors for Diabetes Complications in Primary Care
$524,031Polly H Noel · University Of Texas Hlth Science Center · R18 · FY2011 · DK
Study the role(s) of p53 in embryonic stem cells
$524,002Jing Huang · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Customized nanofibers with preferential lung-targeting properties for treating metastatic pulmonary tumors
$523,990Vanessa Bellat · Weill Medical Coll Of Cornell Univ · R37 · FY2025 · CA
PRAGMATIC CLUSTER RANDOMIZED TRIAL OF AN ASTHMA INTERVENTION FOR URBAN TEENS
$523,906Mei Lu · Henry Ford Health System · R01 · FY2015 · HL
Development of FISH Molecular Diagnostics to support Clinical Trials at NCI
$523,886Svetlana Pack · Division Of Basic Sciences - Nci · ZID · FY2012 · CA
Role of ACER2 in cancer chemoresistance and metastasis
$523,880Cungui Mao · State University New York Stony Brook · R01 · FY2022 · CA
Investigating the heterogeneity of glucose transport in lung adenocarcinoma
$523,834Claudio Scafoglio · University Of California Los Angeles · R01 · FY2020 · CA
Development of a RUVBL1/2 Inhibitor as a Radiosensitizer and Immune Stimulator for NSCLC
$523,830Ralf Kittler · Ut Southwestern Medical Center · R01 · FY2024 · CA
Project 2: Optimization of HPPH for HNSCC Selectivity
$523,814Ravindra K Pandey · Roswell Park Cancer Institute Corp · P01 · FY2016 · CA
Early change in plasma tumor DNA as a patient and trial-level diagnostic in advanced lung cancer
$523,812Cloud Peter Paweletz · Dana-Farber Cancer Inst · R01 · FY2021 · CA
ALPHA 1 AD CARRIERS AND LUNG CANCER RISK
$523,787Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2002 · CA
Chemoprevention of Lung Cancer with Mitochondria-Targeted Honokiol
$523,684Ming You · Methodist Hospital Research Institute · R01 · FY2021 · CA
Cell-of-Origin Footprints of Passenger Mutations in Human Lung Cancer
$523,680Marcin Imielinski · New York University School Of Medicine · R37 · FY2025 · CA
Mechanisms of Dual Inhibition of TGFbeta/PD-L1 in HNSCC
$523,661Xiao-Jing Wang · University Of California At Davis · R01 · FY2023 · DE
Targeting Lymph Node Dependent Immune Tolerance in Cancer
$523,629Edgar G. Engleman · Stanford University · R01 · FY2022 · CA
Mutational Signatures of a Combined Environmental Exposure: Arsenic and Ultraviolet Radiation
$523,581Ke Jian Liu · University Of New Mexico Health Scis Ctr · R01 · FY2020 · ES
Biophysical roles of pre-metastatic niche evolution on transport of circulating tumor cells
$523,568Xuewu Liu · Methodist Hospital Research Institute · U01 · FY2023 · CA
HIERARCHICAL MODELING OF INTERACTIONS IN GENOME-WIDE AND PATHWAY-BASED STUDIES
$523,553David V Conti · University Of Southern California · R01 · FY2010 · ES
Outcomes of Triaged Family Care in Advanced Cancer
$523,527University Of Michigan At Ann Arbor · R01 · FY2005 · CA